4
Tetrahedron Letters
References and notes
1
(a) Rappoport, Z. The Chemistry of the Cyano Group, Wiley: London,
1970; (b) Larock, R. C. Comprehensive Organic Transformations,
Wiley-VCH: New York, 1989; (c) Miller, J. S.; Manson, J. L. Acc.
Chem. Res. 2001, 34, 563-570.
2
3
(a) Nagamura, S.; Kobayashi, E.; Gomi, K.; Saito, H. Bioorg. Med.
Chem. 1996, 4, 1379-1391; (b) Kleemann, A.; Engel, J.; Kutscher,
B.; Reichert, D. Pharmaceutical Substances: Syntheses, Patents,
Applications, 4th Ed, Georg Thieme: Stuttgart, 2001; (c)
Sundermeier, M.; Zapf, A.; Beller, M.; Sans, S. Tetrahedron Lett.
2001, 42, 6707-6710.
For reviews, see: (a) Ellis, G. P.; Romney-Alexander, T. M. Chem.
Rev. 1987, 87, 779-794; (b) Grushin, V. V.; Alper, H. Chem. Rev.
1994, 94, 1047-1062; (c) Anbarasan, P.; Schareina, T.; Beller, M.
Chem. Soc. Rev. 2011, 40, 5049-5067; (d) Kim, J.; Kim, H. J.;
Chang, S.. Angew. Chem. Int. Ed. 2012, 51, 11948-11959; (e) Wen,
Q.; Jin, J.; Zhang, L.; Luo, Y.; Lu, P.; Wang, Y. Tetrahedron Lett.
2014, 55, 1271-1280.
4
(a) Kim, J.; Kim, H.; Chang, S. Org. Lett. 2012, 14, 3924-3927; (b)
Liu, B.; Wang, J.; Zhang, B.; Sun, Y.; Wang, L.; Chen, J.; Cheng, J.
Chem. Commun. 2014, 50, 2315-2317; (c) Ren, X.; Chen, J.; Chen,
F.; Cheng, J. Chem. Commun. 2011, 47, 6725-6727; (d) Ding, S.;
Jiao, N. J. Am. Chem. Soc. 2011, 133, 12374-12377; (e) Yan, Y.;
Yuan, Y.; Jiao, N. Org. Chem. Front. 2014, 1, 1176-1179.
Zhang, L.; Wen, Q.; Jin, J.; Wang, C.; Lu, P.; Wang, Y. Tetrahedron
2013, 69, 4236-4240.
(a) Dhar, M. T. G.; Shen, Z.; Gu, H. H.; Chen, P.; Norris, D.;
Watterson, S. H.; Ballentine, S. K.; Fleener, C. A.; Rouleau, K. A.;
Barrish, J. C.; Townsend, R.; Hollenbaugh D. L.; Iwanowicz, E. J.
Bioorg. Med. Chem. Lett. 2003, 13, 3557-3560; (b) Jiang, B.; Gu, X.
Bioorg. Med. Chem. 2000, 8, 363-371; (c) Kumar, D.; Narayanam,
M. K.; Chang, K. H.; Shah, K. Chem. Biol. Drug Des. 2011, 77,
182-188; (d) Zedda, G.; Simbula, G.; Begala, M.; Pibiri, M.; Floris,
C.; Casu, M.; Casu L.; Tocco, G. Arch. Pharm. 2012, 345, 195-202;
(e) Wu, S.; Wang, L.; Guo, W.; Liu, X.; Liu, J.; Wei, X.; Fang, B. J.
Med. Chem. 2011, 54, 2668-2679; (f) Yuen, O. Y.; Choy, P. Y.;
Chow, W. K.; Wang, W. T.; Kwong, F. Y. J. Org. Chem. 2013, 78,
3374-3378.
5
6
7
8
When 36%~38% HCl solution or PO(OH)3 was used instead of
CF3COOH as additive, no product was detected.
(a) Capdevielle, P.; Lavigne, A.; Maumy, M. Tetrahedron 1990, 46,
2835-2844; (b) Allen, S. E.; Walvoord, R. R.; Padilla-Salinas, R.;
Kozlowski, M. C. Chem. Rev. 2013, 113, 6234-6438.
9
(a) Li, C. J. Acc. Chem. Res. 2009, 42, 335-344; (b) Sureshkumar, D.;
Sud, A.; Klussmann, M. Synlett 2009, 1558-1561.
10 Rousselet, G.; Capdevielle, P.; Maumy, M. Tetrahedron Lett. 1995,
36, 4999-5002.
11 (a) Li, Y.; Xie, Y.; Zhang, R.; Jin, K.; Wang, X.; Duan, C. J. Org.
Chem. 2011, 76, 5444-5449; (b) Wei, Y.; Shi, D.; Wei, Z.; Xu, J.;
Li, J. Chin. J. Org. Chem. 2012, 32, 1126-1130; (c) Muzart, J.
Tetrahedron 2009, 65, 8313-8323; (d) Ding, S.; Jiao, N. Angew.
Chem. Int. Ed. 2012, 51, 9226-9237.
12 For recent reported formylation of indole using amine as the carbon
source, see: (a) Chen, J.; Liu, B.; Liu, D.; Liu, S.; Cheng, J. Adv.
Synth. Catal. 2012, 354, 2438-2441; (b) Zhang, L.; Peng, C.; Zhao,
D.; Wang, Y.; Fu, H.-J.; Shen, Q.; Li, J.-X. Chem. Commun. 2012,
48, 5928-5930; (c) Li, L.-T.; Huang, J.; Li, H.-Y.; Wen, L.-J.; Wang,
P.; Wang, B. Chem. Commun. 2012, 48, 5187-5189; (d) Wu, W.; Su,
W. J. Am. Chem. Soc. 2011, 133, 11924-11927.
13 During the preparation of our work, a copper mediated cyanation of
indoles with DMF as the “CN” source using 2 equiv TBHP as an
oxidant was reported, see: L. Zhang, P. Lu and Y. Wang, Org.
Biomol. Chem. 2015, DOI: 10.1039/C5OB01244A.